BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 38366290)

  • 1. Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance.
    Alemi F; Poornajaf Y; Hosseini F; Vahedian V; Gharekhani M; Shoorei H; Taheri M
    Mol Biol Rep; 2024 Feb; 51(1):308. PubMed ID: 38366290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the role of long non‑coding RNAs and RNA‑binding proteins in regulating DNA damage repair in cancer cells.
    Zou S; Gou X; Wen K
    Int J Mol Med; 2023 Oct; 52(4):. PubMed ID: 37615162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
    Arjumand W; Asiaf A; Ahmad ST
    Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNAs and their RBPs: How to influence the fate of stem cells?
    Zhao C; Xie W; Zhu H; Zhao M; Liu W; Wu Z; Wang L; Zhu B; Li S; Zhou Y; Jiang X; Xu Q; Ren C
    Stem Cell Res Ther; 2022 May; 13(1):175. PubMed ID: 35505438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer.
    Yao ZT; Yang YM; Sun MM; He Y; Liao L; Chen KS; Li B
    Cancer Commun (Lond); 2022 Feb; 42(2):117-140. PubMed ID: 35019235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between long non‑coding RNAs and RNA‑binding proteins in cancer (Review).
    Huang H; Li L; Wen K
    Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34676873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-Binding Proteins as Important Regulators of Long Non-Coding RNAs in Cancer.
    Jonas K; Calin GA; Pichler M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-Damage Response RNA-Binding Proteins (DDRBPs): Perspectives from a New Class of Proteins and Their RNA Targets.
    Dutertre M; Vagner S
    J Mol Biol; 2017 Oct; 429(21):3139-3145. PubMed ID: 27693651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characteristic landscape of lncRNAs classified by RBP-lncRNA interactions across 10 cancers.
    Zhang Q; Wei Y; Yan Z; Wu C; Chang Z; Zhu Y; Li K; Xu Y
    Mol Biosyst; 2017 Jun; 13(6):1142-1151. PubMed ID: 28443890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
    Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
    Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-binding protein ZCCHC4 promotes human cancer chemoresistance by disrupting DNA-damage-induced apoptosis.
    Zhu H; Chen K; Chen Y; Liu J; Zhang X; Zhou Y; Liu Q; Wang B; Chen T; Cao X
    Signal Transduct Target Ther; 2022 Jul; 7(1):240. PubMed ID: 35853866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidimensional crosstalk between RNA-binding proteins and noncoding RNAs in cancer biology.
    Li L; Miao H; Chang Y; Yao H; Zhao Y; Wu F; Song X
    Semin Cancer Biol; 2021 Oct; 75():84-96. PubMed ID: 33722631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational identification of DNA damage-relevant lncRNAs for predicting therapeutic efficacy and clinical outcomes in cancer.
    Liu Y; Huang S; Dong G; Hou C; Zhao Y; Zhang D
    Comput Biol Med; 2024 Mar; 171():108107. PubMed ID: 38412692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage: RNA-binding proteins protect from near and far.
    Dutertre M; Lambert S; Carreira A; Amor-Guéret M; Vagner S
    Trends Biochem Sci; 2014 Mar; 39(3):141-9. PubMed ID: 24534650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNAs and RNA-Binding Proteins in Oxidative Stress, Cellular Senescence, and Age-Related Diseases.
    Kim C; Kang D; Lee EK; Lee JS
    Oxid Med Cell Longev; 2017; 2017():2062384. PubMed ID: 28811863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA Expression Levels Modulate Cell-Type-Specific Splicing Patterns by Altering Their Interaction Landscape with RNA-Binding Proteins.
    Porto FW; Daulatabad SV; Janga SC
    Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31390792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding RNAs: an emerging player in DNA damage response.
    Zhang C; Peng G
    Mutat Res Rev Mutat Res; 2015; 763():202-11. PubMed ID: 25795121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-binding proteins and long noncoding RNAs in intestinal epithelial autophagy and barrier function.
    Xiao L; Rao JN; Wang JY
    Tissue Barriers; 2021 Apr; 9(2):1895648. PubMed ID: 33709880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer.
    Mehta M; Raguraman R; Ramesh R; Munshi A
    Adv Drug Deliv Rev; 2022 Dec; 191():114569. PubMed ID: 36252617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs.
    Jiang W; Xia J; Xie S; Zou R; Pan S; Wang ZW; Assaraf YG; Zhu X
    Drug Resist Updat; 2020 May; 50():100683. PubMed ID: 32146422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.